Form preview

Get the free Proprietary Name Review--Final

Get Form
This document presents the final review of the proprietary name 'Omontys' for a drug application regarding safety and promotional assessments to avoid medication errors.
We are not affiliated with any brand or entity on this form

Get, Create, Make and Sign proprietary name review--final

Edit
Edit your proprietary name review--final form online
Type text, complete fillable fields, insert images, highlight or blackout data for discretion, add comments, and more.
Add
Add your legally-binding signature
Draw or type your signature, upload a signature image, or capture it with your digital camera.
Share
Share your form instantly
Email, fax, or share your proprietary name review--final form via URL. You can also download, print, or export forms to your preferred cloud storage service.

How to edit proprietary name review--final online

9.5
Ease of Setup
pdfFiller User Ratings on G2
9.0
Ease of Use
pdfFiller User Ratings on G2
To use the services of a skilled PDF editor, follow these steps:
1
Log in. Click Start Free Trial and create a profile if necessary.
2
Prepare a file. Use the Add New button to start a new project. Then, using your device, upload your file to the system by importing it from internal mail, the cloud, or adding its URL.
3
Edit proprietary name review--final. Rearrange and rotate pages, add and edit text, and use additional tools. To save changes and return to your Dashboard, click Done. The Documents tab allows you to merge, divide, lock, or unlock files.
4
Save your file. Select it in the list of your records. Then, move the cursor to the right toolbar and choose one of the available exporting methods: save it in multiple formats, download it as a PDF, send it by email, or store it in the cloud.
It's easier to work with documents with pdfFiller than you could have believed. Sign up for a free account to view.

Uncompromising security for your PDF editing and eSignature needs

Your private information is safe with pdfFiller. We employ end-to-end encryption, secure cloud storage, and advanced access control to protect your documents and maintain regulatory compliance.
GDPR
AICPA SOC 2
PCI
HIPAA
CCPA
FDA

How to fill out proprietary name review--final

Illustration

How to fill out Proprietary Name Review--Final

01
Gather necessary information about the drug or product.
02
Ensure you have the correct proprietary name and any alternative names.
03
Complete the application form with accurate details.
04
Provide rationale for the chosen proprietary name.
05
Submit any supporting documents required for the review.
06
Review the submission for completeness before sending it to the appropriate agency.
07
Wait for feedback or approval from the reviewing body.

Who needs Proprietary Name Review--Final?

01
Pharmaceutical companies seeking approval for new drug names.
02
Developers of medical products requiring distinct identities.
03
Regulatory professionals involved in the drug approval process.
Fill form : Try Risk Free
Users Most Likely To Recommend - Summer 2025
Grid Leader in Small-Business - Summer 2025
High Performer - Summer 2025
Regional Leader - Summer 2025
Easiest To Do Business With - Summer 2025
Best Meets Requirements- Summer 2025
Rate the form
4.7
Satisfied
25 Votes

People Also Ask about

For example, Kleenex, band aid, popsicle.
The "proprietary name" or "trade name" of a product is the name that will: be used by the applicant or other entity for the commercial distribution of the product; identify the specific product in the marketplace, following approval by the Center for Biologics Evaluation and Research (CBER).
a name of a product or service that is protected by a patent, copyright, or trademark and cannot be used by another party for commercial purposes without permission of the registered owner or licensee.
Broadly defined as drugs that are marketed under trade names and have patents, which can be a synonym of proprietary drugs in daily use. Strictly speaking, every drug with a trade name is a brand name drug, such as Panadol, a GSK branded paracetamol.
Non-proprietary name is the name for the active ingredient in the medicine that is decided by an expert committee and is understood internationally (WHO, 2013a). Thus, paracetamol/acetaminophen is the non-proprietary name (generic name) while Crocin/Metacin/Meftal/Tylenol etc. are brand names.
We also learn that cellophane and laundromat were once proprietary names (see 'anepronym', a trademarked name that has come to be used generically). These proprietary names are more memorable for a reason: each was developed at a cost of hundreds of thousands of pounds.
Trade Name Also known as brand name or proprietary name. A drug sold by a drug company under a specific name or trademark and that is protected by a patent. Branded products are not generics. A brand can be first-in-class.
WHAT IS A PROPRIETARY NAME? The proprietary name is the exclusive name the sponsor or distributor assigns to a drug product (see Guidance for Industry (GFI) #240). It is commonly known as the brand name or trade name and may include trademarked and non-trademarked words (or numbers).

For pdfFiller’s FAQs

Below is a list of the most common customer questions. If you can’t find an answer to your question, please don’t hesitate to reach out to us.

Proprietary Name Review--Final is a process conducted by regulatory agencies to evaluate and approve the final proprietary name of a drug to ensure it is not misleading and is distinct from other drugs.
Any pharmaceutical company seeking approval for a new drug or a new proprietary name for an existing drug is required to file Proprietary Name Review--Final with the relevant regulatory authority.
To fill out Proprietary Name Review--Final, applicants must complete the designated forms with accurate drug name information, provide rationale for the chosen name, and include any relevant supporting documentation as outlined by the regulatory agency.
The purpose of Proprietary Name Review--Final is to ensure that the proposed drug name is not only legally acceptable but also does not cause confusion with existing drug names, which could potentially lead to medication errors.
The information that must be reported includes the proposed proprietary name, details about the drug, a summary of the name selection process, potential risks associated with the name, and any research supporting the name's distinctiveness.
Fill out your proprietary name review--final online with pdfFiller!

pdfFiller is an end-to-end solution for managing, creating, and editing documents and forms in the cloud. Save time and hassle by preparing your tax forms online.

Get started now
Form preview
If you believe that this page should be taken down, please follow our DMCA take down process here .
This form may include fields for payment information. Data entered in these fields is not covered by PCI DSS compliance.